- call +1-201-465-4211
- email sales@mrinsights.biz
Ophthalmology is a branch of medicine and surgery (both methods are used) that deals with the anatomy, physiology and diseases of the eyeball and orbit. Ophthalmic Equipment are the tool used for ophthalmology.
Scope of the Report:
This report focuses on the Ophthalmology Drugs & Devices in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
The growth of this market is primarily due to the rapid growth in the geriatric population, rising prevalence of eye diseases, technological advancements in ophthalmic devices, increasing government initiatives to control visual impairment.
The worldwide market for Ophthalmology Drugs & Devices is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.
Market Segment by Manufacturers, this report covers
Abbott
Alcon
Allergan
Bausch & Lomb
Carl Zeiss Meditec
Ellex
Essilor
Hoya
Iridex
Johnson & Johnson
Merck & Co.
Nidek Co.
Santen Pharmaceutical
Novartis
Pfizer
Roche Holding
Staar Surgical
Topcon
Ziemer Ophthalmic Systems
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Diagnostic and monitoring devices
Surgical devices
Vision care
Drugs
Market Segment by Applications, can be divided into
Cataract
Glaucoma
Refractive error
Vitreoretinal
There are 15 Chapters to deeply display the global Ophthalmology Drugs & Devices market.
Chapter 1, to describe Ophthalmology Drugs & Devices Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Ophthalmology Drugs & Devices, with sales, revenue, and price of Ophthalmology Drugs & Devices, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Ophthalmology Drugs & Devices, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Ophthalmology Drugs & Devices market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Ophthalmology Drugs & Devices sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Market Overview
1.1 Ophthalmology Drugs & Devices Introduction
1.2 Market Analysis by Type
1.2.1 Diagnostic and monitoring devices
1.2.2 Surgical devices
1.2.3 Vision care
1.2.4 Drugs
1.3 Market Analysis by Applications
1.3.1 Cataract
1.3.2 Glaucoma
1.3.3 Refractive error
1.3.4 Vitreoretinal
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Abbott
2.1.1 Business Overview
2.1.2 Ophthalmology Drugs & Devices Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Abbott Ophthalmology Drugs & Devices Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 Alcon
2.2.1 Business Overview
2.2.2 Ophthalmology Drugs & Devices Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Alcon Ophthalmology Drugs & Devices Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 Allergan
2.3.1 Business Overview
2.3.2 Ophthalmology Drugs & Devices Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Allergan Ophthalmology Drugs & Devices Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 Bausch & Lomb
2.4.1 Business Overview
2.4.2 Ophthalmology Drugs & Devices Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Bausch & Lomb Ophthalmology Drugs & Devices Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 Carl Zeiss Meditec
2.5.1 Business Overview
2.5.2 Ophthalmology Drugs & Devices Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Carl Zeiss Meditec Ophthalmology Drugs & Devices Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 Ellex
2.6.1 Business Overview
2.6.2 Ophthalmology Drugs & Devices Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Ellex Ophthalmology Drugs & Devices Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 Essilor
2.7.1 Business Overview
2.7.2 Ophthalmology Drugs & Devices Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Essilor Ophthalmology Drugs & Devices Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8 Hoya
2.8.1 Business Overview
2.8.2 Ophthalmology Drugs & Devices Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Hoya Ophthalmology Drugs & Devices Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9 Iridex
2.9.1 Business Overview
2.9.2 Ophthalmology Drugs & Devices Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Iridex Ophthalmology Drugs & Devices Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10 Johnson & Johnson
2.10.1 Business Overview
2.10.2 Ophthalmology Drugs & Devices Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Johnson & Johnson Ophthalmology Drugs & Devices Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.11 Merck & Co.
2.11.1 Business Overview
2.11.2 Ophthalmology Drugs & Devices Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 Merck & Co. Ophthalmology Drugs & Devices Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.12 Nidek Co.
2.12.1 Business Overview
2.12.2 Ophthalmology Drugs & Devices Type and Applications
2.12.2.1 Product A
2.12.2.2 Product B
2.12.3 Nidek Co. Ophthalmology Drugs & Devices Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.13 Santen Pharmaceutical
2.13.1 Business Overview
2.13.2 Ophthalmology Drugs & Devices Type and Applications
2.13.2.1 Product A
2.13.2.2 Product B
2.13.3 Santen Pharmaceutical Ophthalmology Drugs & Devices Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.14 Novartis
2.14.1 Business Overview
2.14.2 Ophthalmology Drugs & Devices Type and Applications
2.14.2.1 Product A
2.14.2.2 Product B
2.14.3 Novartis Ophthalmology Drugs & Devices Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.15 Pfizer
2.15.1 Business Overview
2.15.2 Ophthalmology Drugs & Devices Type and Applications
2.15.2.1 Product A
2.15.2.2 Product B
2.15.3 Pfizer Ophthalmology Drugs & Devices Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.16 Roche Holding
2.16.1 Business Overview
2.16.2 Ophthalmology Drugs & Devices Type and Applications
2.16.2.1 Product A
2.16.2.2 Product B
2.16.3 Roche Holding Ophthalmology Drugs & Devices Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.17 Staar Surgical
2.17.1 Business Overview
2.17.2 Ophthalmology Drugs & Devices Type and Applications
2.17.2.1 Product A
2.17.2.2 Product B
2.17.3 Staar Surgical Ophthalmology Drugs & Devices Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.18 Topcon
2.18.1 Business Overview
2.18.2 Ophthalmology Drugs & Devices Type and Applications
2.18.2.1 Product A
2.18.2.2 Product B
2.18.3 Topcon Ophthalmology Drugs & Devices Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.19 Ziemer Ophthalmic Systems
2.19.1 Business Overview
2.19.2 Ophthalmology Drugs & Devices Type and Applications
2.19.2.1 Product A
2.19.2.2 Product B
2.19.3 Ziemer Ophthalmic Systems Ophthalmology Drugs & Devices Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global Ophthalmology Drugs & Devices Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)
3.1 Global Ophthalmology Drugs & Devices Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Ophthalmology Drugs & Devices Revenue and Market Share by Manufacturer (2016-2017)
3.3 Market Concentration Rate
3.3.1 Top 3 Ophthalmology Drugs & Devices Manufacturer Market Share in 2017
3.3.2 Top 6 Ophthalmology Drugs & Devices Manufacturer Market Share in 2017
3.4 Market Competition Trend
4 Global Ophthalmology Drugs & Devices Market Analysis by Regions
4.1 Global Ophthalmology Drugs & Devices Sales, Revenue and Market Share by Regions
4.1.1 Global Ophthalmology Drugs & Devices Sales and Market Share by Regions (2013-2018)
4.1.2 Global Ophthalmology Drugs & Devices Revenue and Market Share by Regions (2013-2018)
4.2 North America Ophthalmology Drugs & Devices Sales and Growth Rate (2013-2018)
4.3 Europe Ophthalmology Drugs & Devices Sales and Growth Rate (2013-2018)
4.4 Asia-Pacific Ophthalmology Drugs & Devices Sales and Growth Rate (2013-2018)
4.5 South America Ophthalmology Drugs & Devices Sales and Growth Rate (2013-2018)
4.6 Middle East and Africa Ophthalmology Drugs & Devices Sales and Growth Rate (2013-2018)
5 North America Ophthalmology Drugs & Devices by Countries
5.1 North America Ophthalmology Drugs & Devices Sales, Revenue and Market Share by Countries
5.1.1 North America Ophthalmology Drugs & Devices Sales and Market Share by Countries (2013-2018)
5.1.2 North America Ophthalmology Drugs & Devices Revenue and Market Share by Countries (2013-2018)
5.2 United States Ophthalmology Drugs & Devices Sales and Growth Rate (2013-2018)
5.3 Canada Ophthalmology Drugs & Devices Sales and Growth Rate (2013-2018)
5.4 Mexico Ophthalmology Drugs & Devices Sales and Growth Rate (2013-2018)
6 Europe Ophthalmology Drugs & Devices by Countries
6.1 Europe Ophthalmology Drugs & Devices Sales, Revenue and Market Share by Countries
6.1.1 Europe Ophthalmology Drugs & Devices Sales and Market Share by Countries (2013-2018)
6.1.2 Europe Ophthalmology Drugs & Devices Revenue and Market Share by Countries (2013-2018)
6.2 Germany Ophthalmology Drugs & Devices Sales and Growth Rate (2013-2018)
6.3 UK Ophthalmology Drugs & Devices Sales and Growth Rate (2013-2018)
6.4 France Ophthalmology Drugs & Devices Sales and Growth Rate (2013-2018)
6.5 Russia Ophthalmology Drugs & Devices Sales and Growth Rate (2013-2018)
6.6 Italy Ophthalmology Drugs & Devices Sales and Growth Rate (2013-2018)
7 Asia-Pacific Ophthalmology Drugs & Devices by Countries
7.1 Asia-Pacific Ophthalmology Drugs & Devices Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Ophthalmology Drugs & Devices Sales and Market Share by Countries (2013-2018)
7.1.2 Asia-Pacific Ophthalmology Drugs & Devices Revenue and Market Share by Countries (2013-2018)
7.2 China Ophthalmology Drugs & Devices Sales and Growth Rate (2013-2018)
7.3 Japan Ophthalmology Drugs & Devices Sales and Growth Rate (2013-2018)
7.4 Korea Ophthalmology Drugs & Devices Sales and Growth Rate (2013-2018)
7.5 India Ophthalmology Drugs & Devices Sales and Growth Rate (2013-2018)
7.6 Southeast Asia Ophthalmology Drugs & Devices Sales and Growth Rate (2013-2018)
8 South America Ophthalmology Drugs & Devices by Countries
8.1 South America Ophthalmology Drugs & Devices Sales, Revenue and Market Share by Countries
8.1.1 South America Ophthalmology Drugs & Devices Sales and Market Share by Countries (2013-2018)
8.1.2 South America Ophthalmology Drugs & Devices Revenue and Market Share by Countries (2013-2018)
8.2 Brazil Ophthalmology Drugs & Devices Sales and Growth Rate (2013-2018)
8.3 Argentina Ophthalmology Drugs & Devices Sales and Growth Rate (2013-2018)
8.4 Colombia Ophthalmology Drugs & Devices Sales and Growth Rate (2013-2018)
9 Middle East and Africa Ophthalmology Drugs & Devices by Countries
9.1 Middle East and Africa Ophthalmology Drugs & Devices Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Ophthalmology Drugs & Devices Sales and Market Share by Countries (2013-2018)
9.1.2 Middle East and Africa Ophthalmology Drugs & Devices Revenue and Market Share by Countries (2013-2018)
9.2 Saudi Arabia Ophthalmology Drugs & Devices Sales and Growth Rate (2013-2018)
9.3 UAE Ophthalmology Drugs & Devices Sales and Growth Rate (2013-2018)
9.4 Egypt Ophthalmology Drugs & Devices Sales and Growth Rate (2013-2018)
9.5 Nigeria Ophthalmology Drugs & Devices Sales and Growth Rate (2013-2018)
9.6 South Africa Ophthalmology Drugs & Devices Sales and Growth Rate (2013-2018)
10 Global Ophthalmology Drugs & Devices Market Segment by Type
10.1 Global Ophthalmology Drugs & Devices Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Ophthalmology Drugs & Devices Sales and Market Share by Type (2013-2018)
10.1.2 Global Ophthalmology Drugs & Devices Revenue and Market Share by Type (2013-2018)
10.2 Diagnostic and monitoring devices Sales Growth and Price
10.2.1 Global Diagnostic and monitoring devices Sales Growth (2013-2018)
10.2.2 Global Diagnostic and monitoring devices Price (2013-2018)
10.3 Surgical devices Sales Growth and Price
10.3.1 Global Surgical devices Sales Growth (2013-2018)
10.3.2 Global Surgical devices Price (2013-2018)
10.4 Vision care Sales Growth and Price
10.4.1 Global Vision care Sales Growth (2013-2018)
10.4.2 Global Vision care Price (2013-2018)
10.5 Drugs Sales Growth and Price
10.5.1 Global Drugs Sales Growth (2013-2018)
10.5.2 Global Drugs Price (2013-2018)
11 Global Ophthalmology Drugs & Devices Market Segment by Application
11.1 Global Ophthalmology Drugs & Devices Sales Market Share by Application (2013-2018)
11.2 Cataract Sales Growth (2013-2018)
11.3 Glaucoma Sales Growth (2013-2018)
11.4 Refractive error Sales Growth (2013-2018)
11.5 Vitreoretinal Sales Growth (2013-2018)
12 Ophthalmology Drugs & Devices Market Forecast (2018-2023)
12.1 Global Ophthalmology Drugs & Devices Sales, Revenue and Growth Rate (2018-2023)
12.2 Ophthalmology Drugs & Devices Market Forecast by Regions (2018-2023)
12.2.1 North America Ophthalmology Drugs & Devices Market Forecast (2018-2023)
12.2.2 Europe Ophthalmology Drugs & Devices Market Forecast (2018-2023)
12.2.3 Asia-Pacific Ophthalmology Drugs & Devices Market Forecast (2018-2023)
12.2.4 South America Ophthalmology Drugs & Devices Market Forecast (2018-2023)
12.2.5 Middle East and Africa Ophthalmology Drugs & Devices Market Forecast (2018-2023)
12.3 Ophthalmology Drugs & Devices Market Forecast by Type (2018-2023)
12.3.1 Global Ophthalmology Drugs & Devices Sales Forecast by Type (2018-2023)
12.3.2 Global Ophthalmology Drugs & Devices Market Share Forecast by Type (2018-2023)
12.4 Ophthalmology Drugs & Devices Market Forecast by Application (2018-2023)
12.4.1 Global Ophthalmology Drugs & Devices Sales Forecast by Application (2018-2023)
12.4.2 Global Ophthalmology Drugs & Devices Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
List of Tables and Figures
Figure Ophthalmology Drugs & Devices Picture
Table Product Specifications of Ophthalmology Drugs & Devices
Figure Global Sales Market Share of Ophthalmology Drugs & Devices
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
